Scientific Interest Group (SIG) Meeting: Navigating the regulatory landscape – from global influences to local engagement
Basel, SwitzerlandDownload the meeting flyer here
Download the meeting flyer here
Download the meeting flyer here
Recording available here: Download the event flyer
Download the webinar flyer and agenda in PDF format.
In collaboration with CARB-X, GNA NOW hosts an Expert Meeting focused on developing a Target Product Profile (TPP) for antibiotics to treat severe enteric infections in low- and middle-income countries (LMICs). The meeting follows the GNA NOW Annual Meeting on 16 September and precedes another prominent event in the AMR space—the European Society of Clinical […]
The 5th Annual Meeting for the COMBINE consortium will take place on October 28th-29th, hosted by GSK at Tres Cantos, Spain.
Time: November 6, 15:00 - 16:30 CEST Speakers: Radu Botgros, M.D., Senior Scientific Officer for the Office of Health Threats and Vaccines Strategy at the European Medicines Agency (EMA). AMR Accelerator’s COMBINE and ERA4TB projects are excited to invite you to an engaging and informative webinar that will introduce you to what regulatory agencies can offer drug and […]
Join us for an insightful webinar on leveraging machine learning (ML) to tackle the challenges of antibiotic drug discovery amidst rising antimicrobial resistance (AMR). Discover how we developed the AntiMicrobial-KG, a comprehensive knowledge graph of in-vitro antibacterial assay data, and used it to train ML models for identifying potential antimicrobial compounds. Learn how our optimised […]
The 6th AMR Accelerator Cross-project Meeting for the AMR Accelerator community will take place on 24 February 2025, 15:00 - 18:30 + Networking dinner, at the Pullman Basel Europe, Switzerland. The registration is open until 30 January 2025 here (https://limesurvey.biocom.de/index.php/512877?lang=en).
Join us for an exclusive webinar featuring leading experts in antimicrobial development as they present success stories in research on novel antibiotics and innovative antibacterial approaches! You will learn: - The latest breakthroughs in tackling multidrug-resistant Gram-negative bacteria. - The development of endolysins—from concept to first-in-human trials. - Key scientific insights, successes, and challenges shaping […]